Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.81 |
| ▸ | PPARD | Q03181 | 5/20 | 0.81 |
| ▸ | PPARA | Q07869 | 5/20 | 0.81 |
| ▸ | F7 | P08709 | 5/20 | 0.81 |
| ▸ | F3 | P13726 | 5/20 | 0.81 |
| ▸ | TERT | O14746 | 3/20 | 0.81 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.81 |
| ▸ | TOP1 | P11387 | 3/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.81 |
| ▸ | FABP4 | P15090 | 3/20 | 0.81 |
| ▸ | MAPT | P10636 | 2/20 | 0.81 |
| ▸ | BLM | P54132 | 2/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.81 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.81 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.81 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.81 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.81 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.81 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2571072 | 1.00 | PPARG (0.81) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2570200 | 1.00 | PPARG (0.81) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2570196 | 1.00 | PPARG (0.81) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL26624477 | 1.00 | PPARG (0.81) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2855222 | 0.98 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2574228 | 0.98 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL10201666 | 0.98 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2858103 | 0.98 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2573063 | 0.98 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL4303654 | 0.98 | PPARG (0.84) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658793-A1 | A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF | ATGC Biotech Pvt Ltd (IN) | 2025-12-10 | — | — | EP | claimed |
| WO-2024161427-A1 | A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF | ATGC BIOTECH PVT LTD (IN) | 2024-08-08 | — | — | WO | claimed |
| US-20260108600-A1 | METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4658793-A1 | A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF | ATGC Biotech Pvt Ltd (IN) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024161427-A1 | A PROCESS FOR PRODUCING PHEROMONES AND APPLICATIONS THEREOF | ATGC BIOTECH PVT LTD (IN) | 2024-08-08 | — | — | WO | disclosed |
| WO-2015128428-A1 | PHEROMONE DISPENSER MADE OF PLASTIC MATERIAL | BASF SE (DE) | 2015-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108600-A1 | METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS | ICOS, ICOSLG, TLR9 | PPARG 2714/4885PPARD 3067/4885PPARA 1843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.